Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections

Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections

Show other versions (1)

OBJECTIVES: To collect data about non-controlled prescribing use of daptomycin and its impact among Brazilian patients with serious Gram positive bacterial infection, as well as the efficacy and safety outcomes. MATERIALS AND METHODS: This is a multi-center, retrospective, non-interventional registr...

Full description

Bibliographic Details
Main Authors:	Artur Timerman, Carlos Brites, Eliana Bicudo, Renato S. Grinbaum, Rubens Costa Filho, Claudia D.M. Carrilho, Andre Bichels, Tânia Barreto
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Daptomycin Methicillin-resistant Staphylococcus aureus Bacteremia Endocarditis Skin diseases Infectious
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000600004&lng=en&tlng=en

Similar Items

Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections
by: Artur Timerman, et al.
Published: (2013-11-01)

Evidence Based Review on Daptomycin Use in the Treatment of Gram(+) Infections
by: Popov D.A., et al.
Published: (2016-11-01)

Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia—A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-08-01)

The Evaluation of Vancomycin and Daptomycin Susceptibility by E-Test Method in Methicillin-Resistant Staphylococcus aureus Isolates
by: Firdevs AKSOY, et al.
Published: (2012-03-01)

Evolution of Multi-Resistance to Vancomycin, Daptomycin, and Linezolid in Methicillin-Resistant Staphylococcus aureus Causing Persistent Bacteremia
by: Chih-Jung Chen, et al.
Published: (2020-07-01)

Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial
by: Matthew P. Cheng, et al.
Published: (2018-05-01)

Daptomycin Experience Between Years 2009-2013: Review of 139 Cases
by: Aslıhan CANDEVİR ULU, et al.
Published: (2014-12-01)

Daptomycin in left-sided endocarditis: A single center experience
by: Burak Açar, et al.
Published: (2017-06-01)

Daptomycin in the treatment of infective endocarditis
by: Popov D.A.
Published: (2018-02-01)

Ceftaroline in the treatment of methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus bacteremia and infective endocarditis in end-stage renal disease
by: Kristen Fuhrmann, et al.
Published: (2013-09-01)

Daptomycin for the treatment of infective endocarditis: When do we use it?
by: Serap Şimşek Yavuz
Published: (2017-06-01)

Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
by: Afzal Husain, et al.
Published: (2018-04-01)

Factors Associated with Daptomycin-Induced Eosinophilic Pneumonia
by: Kazuhiro Ishikawa, et al.
Published: (2022-02-01)

Genomic and Long-Term Transcriptomic Imprints Related to the Daptomycin Mechanism of Action Occurring in Daptomycin- and Methicillin-Resistant Staphylococcus aureus Under Daptomycin Exposure
by: Viviana Cafiso, et al.
Published: (2020-08-01)

Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
by: Maddalena Peghin, et al.
Published: (2019-08-01)

Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis
by: Eun-Jeong Joo, et al.
Published: (2019-11-01)

Spontaneous bacterial peritonitis due to methicillin-resistant Staphylococcus aureus in a patient with cirrhosis: the potential role for daptomycin and review of the literature
by: Marco Falcone, et al.
Published: (2015-09-01)

Daptomycin plus ceftaroline salvage therapy for persistent Staphylococcus epidermidis bacteremia
by: Hayden Zhang, et al.
Published: (2024-02-01)

Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci: A systematic review and meta-analysis
by: Takumi Umemura, et al.
Published: (2024-04-01)

In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018–2020
by: Xu Y, et al.
Published: (2021-12-01)

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible <it>Staphylococcus aureus</it>: Case report
by: Hsiao Chen-Yuan, et al.
Published: (2011-05-01)

The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection
by: Yu-Chung Chuang, et al.
Published: (2022-12-01)

Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it>Staphylococcus aureus </it>in a renal transplant recipient with Fabry-Anderson disease
by: Polilli Ennio, et al.
Published: (2012-03-01)

A case of endocarditis with cerebral embolism successfully treated with daptomycin
by: Roberta Doria, et al.
Published: (2011-11-01)

İnvestigation of Daptomycin Sensitivities in Methicillin Resistant Staphylococcus Aureus and Vancomycin Resistant Enterococcal Strains by İn Vitro E-Test Method
by: Nuray Arı, et al.
Published: (2021-10-01)

Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis
by: Alberto Enrico Maraolo, et al.
Published: (2021-08-01)

Daptomycin in the Treatment of Diabetic Foot Infections without Osteomyelitis; A Multicenter Study
by: Meltem IŞIKGÖZ TAŞBAKAN, et al.
Published: (2017-12-01)

Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant <i>Staphylococcus</i> <i>aureus</i> with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
by: Masaru Samura, et al.
Published: (2022-03-01)

Role of Daptomycin in the Induction and Persistence of the Viable but Non-Culturable State of Staphylococcus Aureus Biofilms
by: Sonia Pasquaroli, et al.
Published: (2014-09-01)

Daptomycin: a new treatment for insidious infections due to gram-positive pathogens
by: Swiss Medical Weekly
Published: (2008-02-01)

Beta Lactams Plus Daptomycin Combination Therapy for Infective Endocarditis: An Italian National Survey (BADAS)
by: Silvia Corcione, et al.
Published: (2022-01-01)

Daptomycin Use for Persistent Coagulase-Negative Staphylococcal Bacteremia in a Neonatal Intensive Care Unit
by: Eleni Papachatzi, et al.
Published: (2024-03-01)

Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure
by: Shuguang Li, et al.
Published: (2017-11-01)

The Use of Daptomycin and Quinolones Combination in Staphylococcus aureus Bacteremia: An In Vitro Synergistic Study
by: Derya KETEN, et al.
Published: (2013-09-01)

Daptomycin for Treatment of <i>S. Epidermidis</i> Endocarditis in an Extremely Preterm Neonate—Outcome and Perspectives
by: Chiara Minotti, et al.
Published: (2022-03-01)

Effectiveness of daptomycin against infective endocarditis caused by highly penicillin-resistant viridans group streptococci
by: Takahiro Matsuo, et al.
Published: (2021-01-01)

Bacterial cell membranes and their role in daptomycin resistance: A review
by: April H. Nguyen, et al.
Published: (2022-11-01)

Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection
by: Yu-Jui Chang, et al.
Published: (2017-11-01)

A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model
by: Jann-Tay Wang, et al.
Published: (2022-10-01)

Catalase Protects Biofilm of <i>Staphylococcus aureus</i> against Daptomycin Activity
by: Cristina El Haj, et al.
Published: (2021-04-01)